Mycophenolate mofetilIntervention1 paperPubChem 5281078ChEBI 8764Human trial1LatestNov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 monthsbioRxiv·24 NovCoordinated circulating and tissue-based T cell responses precede xenograft rejectionPreprint: case reportBlood and immune systemPaperFrontiers in Aging·30 OctSirolimus use in allogeneic hematopoietic cell transplant recipients: assessing its senotherapeutic role in a high risk populationCohort study in peopleRapamycinPaperTransplantation·11 MayEnhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive RegimensRandomised trial in 32 peopleKidneyPaper
bioRxiv·24 NovCoordinated circulating and tissue-based T cell responses precede xenograft rejectionPreprint: case reportBlood and immune systemPaper
Frontiers in Aging·30 OctSirolimus use in allogeneic hematopoietic cell transplant recipients: assessing its senotherapeutic role in a high risk populationCohort study in peopleRapamycinPaper
Transplantation·11 MayEnhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive RegimensRandomised trial in 32 peopleKidneyPaper